Who owns Impax Laboratories?

Key details on Impax Laboratories (Ticker: IPXL)

Who owns Impax Laboratories?

Is IPXL a good stock to own? Find out who bought Impax Laboratories, who sold Impax Laboratories (IPXL) stock, and who holds a large position in Impax Laboratories.

Fund Name Number of Shares Share Valuation As Of
OrbiMed Advisors 6.66M $157.79M Sept. 30, 2014
BlackRock Fund Advisors 4.70M $111.40M Sept. 30, 2014
Vanguard 4.49M $106.36M Sept. 30, 2014
Inves 3.58M $84.78M Sept. 30, 2014
Visium Asset Management 3.40M $52.50M March 31, 2013
STATE STREET CORPORATION 2.72M $64.54M Sept. 30, 2014
Wells Fargo & Company 2.71M $55.10M June 30, 2012
FMR 2.30M $54.47M Sept. 30, 2014
UBS GLOBAL ASSET MANAGEMENT AMERICAS 2.23M $52.93M Sept. 30, 2014
Wellington Management Company 2.23M $45.64M Dec. 31, 2012
BlackRock Institutional Trust Company, N.A. 1.84M $43.54M Sept. 30, 2014
TCW 1.66M $42.96M Sept. 30, 2012
ALLIANCEBERNSTEIN 1.61M $32.97M Dec. 31, 2012
Ameriprise Financial 1.57M $47.22M June 30, 2014
Apex Capital 1.49M $29.61M June 30, 2013
Ranger Investment Management 1.47M $30.22M Dec. 31, 2012
DIMENSIONAL FUND ADVISORS 1.43M $33.80M Sept. 30, 2014
CITADEL ADVISORS 1.42M $29.19M Sept. 30, 2013
ING Investment Management Co Address: 10 State House Square 1.41M $28.42M Dec. 31, 2011
Name Highfields Capital Management 1.40M $33.19M Sept. 30, 2014
Luther King Capital Management Corporation 1.35M $27.66M Dec. 31, 2012
RS INVESTMENT MANAGEMENT 1.33M $35.10M March 31, 2014
Jennison Associates 1.32M $31.33M Sept. 30, 2014
Ascend Capital 1.30M $26.01M June 30, 2013
NWQ INVESTMENT MANAGEMENT 1.30M $30.66M Sept. 30, 2014
LORD, ABBETT & CO 1.27M $38.18M June 30, 2014
FRIESS ASSOCIATES 1.22M $24.54M Dec. 31, 2011

Who sold Impax Laboratories?

Fund Name Date Sold Number of Shares Sold Share Valuation
First Trust Advisors June 30, 2011 1.57M $34.19M
Nuveen Asset Management June 30, 2011 1.27M $27.63M
Damian Sousa June 30, 2011 1.21M $26.35M